Robertet SA (LON:0NZN)
London · Delayed Price · Currency is GBP · Price in EUR | Market Cap | 1.50B +11.1% |
| Revenue (ttm) | 736.24M +4.5% |
| Net Income | 90.23M +14.8% |
| EPS | 41.25 +9.8% |
| Shares Out | n/a |
| PE Ratio | 16.61 |
| Forward PE | 17.14 |
| Dividend | 8.54 (1.07%) |
| Ex-Dividend Date | Jun 27, 2025 |
| Volume | 170 |
| Average Volume | 460 |
| Open | 788.00 |
| Previous Close | 783.00 |
| Day's Range | 787.88 - 794.00 |
| 52-Week Range | 776.00 - 915.00 |
| Beta | 0.34 |
| RSI | 41.89 |
| Earnings Date | Sep 17, 2026 |
About Robertet
Robertet SA produces and sells perfumes, aromas, and natural products. The company operates in four segments: Raw materials, Fragrances, Flavors, and Active Ingredients. It also produces organic essential oils and active ingredients. The company operates in North America, Latin America, Europe, Africa, and the Middle East. Robertet SA was founded in 1850 and is headquartered in Grasse, France. [Read more]
Financial Performance
In 2025, Robertet's revenue was 843.95 million, an increase of 4.50% compared to the previous year's 807.63 million. Earnings were 103.43 million, an increase of 14.83%.
Financial numbers in EUR Financial StatementsNews
Robertet Earnings Call Transcript: H2 2025
Strong organic growth and margin expansion in 2025, with EBITDA margin up to 20.6% and net income rising 14.8%. Facing headwinds from FX, raw material, and transport costs, but maintaining disciplined investment and M&A strategy. Guidance for 2026 is cautious, targeting 5% revenue growth.
ROBERTET INVESTS IN AETHERA BIOTECH, A EUROPEAN PIONEER IN ACTIVE COSMETIC INGREDIENTS
ROBERTET INVESTS IN AETHERA BIOTECH, A EUROPEAN PIONEER IN ACTIVE COSMETIC INGREDIENTS Entering plant-based biotechnologies to advance Robertet's “Augmented Naturality” strategy Strengthening Robertet...